FI973691A0 - Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäviä koostumuksia - Google Patents

Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäviä koostumuksia

Info

Publication number
FI973691A0
FI973691A0 FI973691A FI973691A FI973691A0 FI 973691 A0 FI973691 A0 FI 973691A0 FI 973691 A FI973691 A FI 973691A FI 973691 A FI973691 A FI 973691A FI 973691 A0 FI973691 A0 FI 973691A0
Authority
FI
Finland
Prior art keywords
ace inhibitor
felodipine
salt
composition containing
containing amlodipine
Prior art date
Application number
FI973691A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973691A (fi
Inventor
Anne B Cropp
Allen R Kraska
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI973691A0 publication Critical patent/FI973691A0/fi
Publication of FI973691A publication Critical patent/FI973691A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI973691A 1995-03-16 1997-09-15 Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäviä koostumuksia FI973691A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40510895A 1995-03-16 1995-03-16
PCT/IB1996/000145 WO1996028185A2 (en) 1995-03-16 1996-02-26 Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor

Publications (2)

Publication Number Publication Date
FI973691A0 true FI973691A0 (fi) 1997-09-15
FI973691A FI973691A (fi) 1997-09-15

Family

ID=23602311

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973691A FI973691A (fi) 1995-03-16 1997-09-15 Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäviä koostumuksia

Country Status (12)

Country Link
US (1) US6245787B1 (es)
EP (1) EP0804229B1 (es)
JP (2) JPH11500140A (es)
AT (1) ATE235251T1 (es)
CA (1) CA2215234C (es)
DE (1) DE69626958T2 (es)
DK (1) DK0804229T3 (es)
ES (1) ES2193233T3 (es)
FI (1) FI973691A (es)
MX (1) MX9706957A (es)
PT (1) PT804229E (es)
WO (1) WO1996028185A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
US6521647B2 (en) 2000-04-04 2003-02-18 Pfizer Inc. Treatment of renal disorders
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
EP1695716A2 (en) * 2000-12-26 2006-08-30 Sankyo Company, Limited Medicinal compositions containing diuretics and insulin sensitizers
TW200306799A (en) * 2002-05-17 2003-12-01 Novartis Ag Combination of organic compounds
US20040072879A1 (en) * 2002-10-10 2004-04-15 Dr. Reddy's Laboratories Limited Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
HUP0401170A2 (en) * 2004-06-10 2006-09-28 Richter Gedeon Vegyeszet Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for
US8158146B2 (en) 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
US20070142473A1 (en) * 2005-12-15 2007-06-21 Lawrence Solomon Dosage forms and methods using ethacrynic acid
JP2010500374A (ja) * 2006-08-08 2010-01-07 エーシーシーユー−ブレイク テクノロジーズ，インク． 複数の活性セグメントを含む薬剤の錠剤
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
SG183449A1 (en) 2010-02-24 2012-09-27 Sanofi Aventis Deutschland Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation
RU2483728C1 (ru) * 2011-09-29 2013-06-10 Общество с ограниченной ответственностью "Озон" Комбинированное гипотензивное средство и способ его получения
US20150272930A1 (en) * 2014-04-01 2015-10-01 AILEX Pharmaceuticals PVT. LTD. Fixed Dosage Formulations of Angiotensin Converting Enzyme (ACE) inhibitor and the Diuretic Chlorthalidone
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
DE3633496A1 (de) 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
NZ242724A (en) 1991-05-15 1994-09-27 Du Pont Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker
EP0795327A1 (en) 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
CA2215234C (en) 2001-12-11
EP0804229A2 (en) 1997-11-05
DE69626958T2 (de) 2004-03-18
CA2215234A1 (en) 1996-09-19
WO1996028185A2 (en) 1996-09-19
JP2003286170A (ja) 2003-10-07
FI973691A (fi) 1997-09-15
DK0804229T3 (da) 2003-04-22
EP0804229B1 (en) 2003-03-26
PT804229E (pt) 2003-06-30
JPH11500140A (ja) 1999-01-06
WO1996028185A3 (en) 1996-10-17
US6245787B1 (en) 2001-06-12
ATE235251T1 (de) 2003-04-15
MX9706957A (es) 1997-11-29
DE69626958D1 (de) 2003-04-30
ES2193233T3 (es) 2003-11-01

Similar Documents

Publication Publication Date Title
FI973691A0 (fi) Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäviä koostumuksia
DE69105501D1 (de) (+)-alpha-(2,3 dimethoxyphenyl)-1-[2-(fluorophenyl)ethyl]-4-piperidinmethanol.
NO924326L (no) Antitrombosemidler
LU90829I2 (fr) Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables
LU90769I2 (fr) Capecitabine et ses d-riv-es pharmaceutiquement acceptables (xeloda)
LU91452I2 (fr) "Mycafungine et ses sels pharmaceutiquement acceptables(MYCAMINEr)"
LU90069I2 (fr) Lercanidipine et ses sels et dérivés pharmaceutiquement acceptables (Zanidip)
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
YU32196A (sh) Upotreba jedinjenja za pripremanje leka korisnog za inhibiranje migracije vaskularnih ćelija glatkog mišića
LU88843I2 (fr) Ropivacaine et ses dérivés pharmaceutiquement acceptables (Naropine R)
DE3852389D1 (de) Rissformungsverhütung in implantierten Prothesen.
DE69631542D1 (de) Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen
IT9020276A0 (it) Derivati di tieno-triazolo-diazepine, un procedimento per la loro preparazione e composizioni terapeutiche che li contengono
FI955679A (fi) Piperidiinijohdannaisia, niiden valmistus ja käyttö
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
IT8819958A0 (it) Derivati alchiltiobenzimidazolici attivi farmacologicamente eprocedimento per la loro preparazione.
DK1058544T3 (da) Inhibition af TNF-aktivitet med præparater, der omfatter heparin og oplöselige TNF-receptorer
MX9202595A (es) Derivado de nucleosido.
IE840977L (en) Pharmaceutical preparations
ES2041987T3 (es) Metodo y composicion para analgesia oftalmica empleando rodocaina.
ATE210986T1 (de) Zubereitungen von 1,5-benzodiazepinderivaten mit cck-antagonistischen oder agonistischer wirkung mit enterischem überzug
FI874823A0 (fi) Farmaceutisk komposition foer anvaendning mot hypertension och kongestiv hjaertinsufficiens.
IT1213568B (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
GB8915315D0 (en) Pharmaceutical compositions for use against hypertension and congestive heart failure
IT1239442B (it) Procedimento per la preparazione di una soluzione concentrata di solfito di sodio e solfato di sodio proveniente dalla desolforazione di gas di combustione.

Legal Events

Date Code Title Description
FD Application lapsed